Icici Bk LTD (IBN) Shareholder Sarasin & Partners Llp Has Decreased Position; Brighton Jones Upped Its Position in Amgen (AMGN) as Market Value Declined

ICICI Bank Limited (NYSE:IBN) Logo

Sarasin & Partners Llp decreased its stake in Icici Bk Ltd (IBN) by 4.81% based on its latest 2018Q3 regulatory filing with the SEC. Sarasin & Partners Llp sold 198,993 shares as the company’s stock rose 1.54% while stock markets declined. The institutional investor held 3.94 million shares of the commercial banks company at the end of 2018Q3, valued at $33.46 million, down from 4.14M at the end of the previous reported quarter. Sarasin & Partners Llp who had been investing in Icici Bk Ltd for a number of months, seems to be less bullish one the $30.53B market cap company. The stock decreased 1.76% or $0.17 during the last trading session, reaching $9.5. About 7.82M shares traded or 10.82% up from the average. ICICI Bank Limited (NYSE:IBN) has declined 2.63% since February 14, 2018 and is downtrending. It has underperformed by 2.63% the S&P500. Some Historical IBN News: 13/03/2018 – ICICI Securities Lowers Valuation Ahead Of Primary Market Debut Next Week; 26/04/2018 – ICICI BANK – BOARD MEETING UPDATE; 14/03/2018 – ICICI SECURITIES LTD – IPO TO OPEN ON MARCH 22, CLOSE ON MARCH 26; 03/04/2018 – Times of India: Explain ‘funds from Mauritius’, income tax department tells ICICI MD Chanda Kochhar’s husband Deepak; 12/04/2018 – INDIA MARKET REGULATOR INITIATES PROBE INTO ALLEGED CORPORATE GOVERNMANCE BREACHES AT ICICI BANK – ET NOW CITING; 18/04/2018 – Business Std.in: ICICI Bank chairman meets MFs over succession plan, if Kochhar steps down; 16/04/2018 – Moneycontrol.in: ICICI matter: Finance Ministry looking at BBB member Pradeep Kumar’s stint at Avista Advisory; 12/04/2018 – INDIA REGULATOR IS SAID TO PROBE CORP GOVERNANCE AT ICICI: ET; 13/04/2018 – BSE SEEKS CLARIFICATION FROM ICICI BANK ON REPORT OF SEBI PROBE; 04/04/2018 – India Today: Chairman MK Sharma evaluated ICICI-Videocon deal process, not third party

Brighton Jones Llc increased its stake in Amgen Incorporated (AMGN) by 246.83% based on its latest 2018Q3 regulatory filing with the SEC. Brighton Jones Llc bought 6,472 shares as the company’s stock declined 4.15% with the market. The institutional investor held 9,094 shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $1.89 million, up from 2,622 at the end of the previous reported quarter. Brighton Jones Llc who had been investing in Amgen Incorporated for a number of months, seems to be bullish on the $119.06B market cap company. The stock increased 0.29% or $0.55 during the last trading session, reaching $188.98. About 2.17M shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 11.57% since February 14, 2018 and is uptrending. It has outperformed by 11.57% the S&P500. Some Historical AMGN News: 26/04/2018 – ABBVIE INC – QTRLY GLOBAL HUMIRA SALES $4.71 BLN, UP 14.4 PCT ON REPORTED BASIS; 08/05/2018 – LUPIN SUBMITS NEW DRUG APPLICATION FOR ETANERCEPT BIOSIMILAR; 08/03/2018 – Amgen Announces Final Results Of Tender Offer; 24/04/2018 – AMGEN INC – 2018 TOTAL REVENUE OUTLOOK REVISED TO $21.9 BLN TO $22.8 BLN; 03/05/2018 – COHERUS BIOSCIENCES – RE-SUBMISSION OF BLA FOR CHS-1701, A PEGFILGRASTIM (NEULASTA┬«) BIOSIMILAR CANDIDATE, TO U.S. FDA UNDER 351(K) PATHWAY; 17/05/2018 – Mary MacDonald: Breaking: FDA approves new drug for migraines by @Amgen and Novartis; 29/05/2018 – COHERUS BIOSCIENCES SUBMITTED DAY 181 RESPONSES ON NEULASTA; 17/05/2018 – FDA Approves Anti-migraine Drug From Novartis, Amgen — MarketWatch; 17/05/2018 – FDA OKS AIMOVIG FOR MIGRAINE; 17/05/2018 – FDA GRANTED APPROVAL OF AIMOVIG TO AMGEN

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Nasdaq.com which released: “Key Takeaways from Eli Lilly’s (LLY) Q4 Earnings Report – Nasdaq” on February 13, 2019, also Nasdaq.com with their article: “Amgen Earnings: AMGN Stock Slips on Q4 Earnings Beat, Weak Q1 Guidance – Nasdaq” published on January 29, 2019, Nasdaq.com published: “Amgen (AMGN) to Report Q4 Earnings: What’s in the Cards? – Nasdaq” on January 28, 2019. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Finance.Yahoo.com and their article: “2 Days Left To Cash In On Amgen Inc. (NASDAQ:AMGN) Dividend – Yahoo Finance” published on February 11, 2019 as well as Nasdaq.com‘s news article titled: “Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” with publication date: February 08, 2019.

Among 28 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 17 Hold. Therefore 39% are positive. Amgen Inc. had 102 analyst reports since August 3, 2015 according to SRatingsIntel. As per Friday, July 21, the company rating was maintained by Oppenheimer. The rating was maintained by Oppenheimer with “Buy” on Wednesday, July 12. Barclays Capital maintained it with “Equal-Weight” rating and $190 target in Friday, October 13 report. Oppenheimer maintained Amgen Inc. (NASDAQ:AMGN) rating on Monday, June 5. Oppenheimer has “Buy” rating and $18900 target. Cowen & Co maintained Amgen Inc. (NASDAQ:AMGN) on Thursday, July 20 with “Buy” rating. The rating was initiated by Citigroup with “Neutral” on Thursday, February 25. The rating was maintained by Mizuho on Friday, July 14 with “Buy”. The firm has “Outperform” rating by Oppenheimer given on Tuesday, December 13. As per Tuesday, October 3, the company rating was maintained by Cowen & Co. The company was upgraded on Wednesday, February 1 by Bank of America.

Brighton Jones Llc, which manages about $2.52 billion and $813.52 million US Long portfolio, decreased its stake in Tesla Motors Inc (NASDAQ:TSLA) by 2,153 shares to 2,929 shares, valued at $776,000 in 2018Q3, according to the filing. It also reduced its holding in Vanguard Total Stock Market Etf (VTI) by 8,587 shares in the quarter, leaving it with 286,744 shares, and cut its stake in Amazon.Com (NASDAQ:AMZN).

Investors sentiment decreased to 0.87 in Q3 2018. Its down 0.12, from 0.99 in 2018Q2. It is negative, as 49 investors sold AMGN shares while 550 reduced holdings. 130 funds opened positions while 393 raised stakes. 470.42 million shares or 2.68% less from 483.36 million shares in 2018Q2 were reported. Patten And Patten Tn has 2,771 shares. Jacobs Levy Equity Mngmt accumulated 6,294 shares. The Michigan-based Lvm Capital Mgmt Ltd Mi has invested 3.75% in Amgen Inc. (NASDAQ:AMGN). American Assets Invest Mngmt Ltd Liability holds 0.35% or 10,190 shares. Northern holds 8.77 million shares. Fulton Breakefield Broenniman Limited Liability has 15,592 shares. Cornerstone Advsrs has 46,000 shares. 35,445 were accumulated by Lee Danner Bass. The Oklahoma-based Bridgecreek Invest Mgmt Ltd has invested 0.39% in Amgen Inc. (NASDAQ:AMGN). Aperio Ltd Liability Company accumulated 481,640 shares. Tiedemann Advsrs Ltd Liability has invested 0.14% in Amgen Inc. (NASDAQ:AMGN). Raymond James Assocs has 0.23% invested in Amgen Inc. (NASDAQ:AMGN). Stone Run Cap Ltd Llc invested 0.13% in Amgen Inc. (NASDAQ:AMGN). Washington Trust Co stated it has 0.56% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Opus Capital Limited Liability Corp reported 4,540 shares or 0.21% of all its holdings.

Since November 29, 2018, it had 0 buys, and 3 selling transactions for $4.65 million activity. Jacks Tyler had sold 20,000 shares worth $3.91 million. SUGAR RONALD D had sold 2,000 shares worth $380,000 on Thursday, February 7.

Among 7 analysts covering ICICI Bank (NYSE:IBN), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. ICICI Bank had 11 analyst reports since August 19, 2015 according to SRatingsIntel. As per Wednesday, August 19, the company rating was upgraded by Zacks. UBS upgraded ICICI Bank Limited (NYSE:IBN) on Friday, October 21 to “Buy” rating. The stock has “Hold” rating by Zacks on Thursday, September 3. The stock has “Buy” rating by Goldman Sachs on Monday, September 14. Jefferies upgraded the stock to “Buy” rating in Monday, October 30 report. Morgan Stanley initiated ICICI Bank Limited (NYSE:IBN) on Tuesday, January 16 with “Buy” rating. The stock of ICICI Bank Limited (NYSE:IBN) has “Buy” rating given on Monday, October 24 by Goldman Sachs. The rating was upgraded by Credit Suisse to “Outperform” on Thursday, April 21. The stock of ICICI Bank Limited (NYSE:IBN) has “Neutral” rating given on Tuesday, May 3 by Goldman Sachs. The stock of ICICI Bank Limited (NYSE:IBN) has “Sell” rating given on Tuesday, August 25 by Zacks.

More recent ICICI Bank Limited (NYSE:IBN) news were published by: Fool.com which released: “3 Reasons Visa Inc. Is a Buy – The Motley Fool” on November 11, 2018. Also Benzinga.com published the news titled: “21 Stocks Moving In Friday’s Pre-Market Session – Benzinga” on January 25, 2019. Seekingalpha.com‘s news article titled: “AMD, BA, VALE among premarket gainers – Seeking Alpha” with publication date: January 30, 2019 was also an interesting one.

Sarasin & Partners Llp, which manages about $17.00B and $5.31 billion US Long portfolio, upped its stake in Middleby Corp (NASDAQ:MIDD) by 12,000 shares to 67,000 shares, valued at $8.67M in 2018Q3, according to the filing. It also increased its holding in Ishares Tr (CSJ) by 15,321 shares in the quarter, for a total of 30,642 shares, and has risen its stake in Apple Inc (NASDAQ:AAPL).

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart